FDA Inspection 1046964 — Rohto Pharmaceutical Co., Ltd. (Ueno Plant)

Rohto Pharmaceutical Co., Ltd. (Ueno Plant) — FEI 3003722237

The FDA completed an inspection of Rohto Pharmaceutical Co., Ltd. (Ueno Plant) on Mar 2, 2018 in Iga. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 3 citations were issued during this inspection. Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Mar 2, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Iga (Japan)

Citations

IDCFRDescription
135821 CFR 211.100(b)SOPs not followed / documented
136121 CFR 211.100(a)Absence of Written Procedures
145121 CFR 211.113(b)Procedures for sterile drug products

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.